Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors
Molecules · 04.01.2023 · 28 (2) · 501
DOI: 10.3390/molecules28020501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 04.01.2023. Verfasst von M Akiful Haque und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, School of Pharmacy, Anurag University, Ghatkesar, Hyderabad 500088, India. Hauptthemen laut MEDLINE: Folic Acid Antagonists. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Palermo.
Abstract (Originalsprache)
The present work describes the design and development of seventeen pyrimidine-clubbed benzimidazole derivatives as potential dihydrofolate reductase (DHFR) inhibitors. These compounds were filtered by using ADMET, drug-likeness characteristics calculations, and molecular docking experiments. Compounds 27, 29, 30, 33, 37, 38, and 41 were chosen for the synthesis based on the results of the in silico screening. Each of the synthesized compounds was tested for its in vitro antibacterial and antifungal activities using a variety of strains. All the compounds showed antibacterial properties against Gram-positive bacteria (Staphylococcus aureus and Staphylococcus pyogenes) as well as Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa). Most of the compounds either had a higher potency than chloramphenicol or an equivalent potency to ciprofloxacin. Compounds 29 and 33 were effective against all the bacterial and fungal strains. Finally, the 1,2,3,4-tetrahydropyrimidine-2-thiol derivatives with a 6-chloro-2-(chloromethyl)-1H-benzo[d]imidazole moiety are potent enough to be considered a promising lead for the discovery of an effective antibacterial agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, School of Pharmacy, Anurag University, Ghatkesar, Hyderabad 500088, India.
- National College of Pharmacy, Kozhikode 673602, India.
- Department of Pharmaceutics, Himachal Institute of Pharmaceutical Education and Research (HIPER), Bela, Nadaun, Hamirpur 177042, India.
- Department of Chemistry, Faculty of Applied Science, Umm-Al-Qura University, Makkah 24382, Saudi Arabia.
- Department of Pharmaceutical Chemistry, Pravara Rural College of Pharmacy, Loni 413736, India.
- Department of Pharmaceutical Chemistry, Government College of Pharmacy, Karad 415124, India.
ORCID-Profile: Fahadul Islam, Giulia Culletta, Marco Tutone, Sharuk L Khan
Förderung
- University of Palermo
Zitieren
APA
Haque, M. A., Marathakam, A., Rana, R., Almehmadi, S. J., Tambe, V. B., Charde, M. S., Islam, F., Siddiqui, F. A., Culletta, G., Almerico, A. M., Tutone, M., & Khan, S. L. (2023). Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors. Molecules, 28(2), 501. https://doi.org/10.3390/molecules28020501
Vancouver
Haque MA, Marathakam A, Rana R, Almehmadi SJ, Tambe VB, Charde MS, et al. Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors. Molecules. 2023;28(2):501. doi:10.3390/molecules28020501
BibTeX
@article{Haque2023,
author = {Haque, M Akiful and Marathakam, Akash and Rana, Ritesh and Almehmadi, Samar J and Tambe, Vishal B and Charde, Manoj S and Islam, Fahadul and Siddiqui, Falak A and Culletta, Giulia and Almerico, Anna Maria and Tutone, Marco and Khan, Sharuk L},
title = {Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors},
journal = {Molecules},
year = {2023},
volume = {28},
number = {2},
pages = {501},
doi = {10.3390/molecules28020501}
}
EUVIMED